Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

151 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

151

Total Reports

Deaths Reported

990.0%

Death Rate

Active Ingredients

Leptospira-Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract

Administration Routes

SubcutaneousParenteralUnknownOralOther

Species Affected

Dog 151

Most Affected Breeds

Retriever - Labrador 16

Shih Tzu 13

Retriever - Golden 10

Chihuahua 9

Shepherd Dog - Australian 6

Crossbred Canine/dog 5

Maltese 4

Bulldog - French 4

Pit Bull 4

Terrier - Yorkshire 4

Most Reported Reactions

Vomiting 51

Lethargy (see also Central nervous system depression in 'Neurological') 29

Other abnormal test result NOS 20

Elevated alanine aminotransferase (ALT) 13

Not eating 13

Leucocytosis NOS 13

Lethargy (see also Central nervous system depression in Neurological) 13

Abnormal ultrasound finding 11

Death 11

Neutrophilia 11

Lack of efficacy - NOS 11

Anorexia 10

Outcome Breakdown

Recovered/Normal

53 (35.1%)

Outcome Unknown

43 (28.5%)

Ongoing

40 (26.5%)

Died

11 (7.3%)

Euthanized

4 (2.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.